期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Repurposing FDA-approved drugs for SARS- CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction 被引量:2
1
作者 Wenyu Fu yujianan chen +7 位作者 Kaidi Wang Aubryanna Hettinghouse Wenhuo Hu Jing-Quan Wang Zi-Ning Lei Zhe-Sheng chen Kenneth A.Stapleford Chuan-ju Liu 《Protein & Cell》 SCIE CSCD 2021年第7期586-591,共6页
Dear Editor,The ongoing coronavirus disease 2019(COVID-19)global pandemic is caused by a novel coronavirus,severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),which instigates severe and often fatal symptoms.A... Dear Editor,The ongoing coronavirus disease 2019(COVID-19)global pandemic is caused by a novel coronavirus,severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),which instigates severe and often fatal symptoms.As of September 4th,2020,more than 26 million cases of COVID-19 and almost 900,000 deaths have been reported to WHO.Based on Kissler and colleagues’modeled projections of future viral transmission scenarios,a resurgence in SARS-CoV-2 could occur over the next five years(Kissler et al.,2020). 展开更多
关键词 ACE2 DRUGS ACUTE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部